Global Radiotherapy Market, By Therapy (Beam Radiotherapy, Brachytherapy, Systemic Radiotherapy), By Product Type (External Beam Radiotherapy, Internal Radiotherapy Products, Radiotherapy Softwares, Systemic Radiotherapy), By Application (Prostrate Cancer, Breast Cancer, Lung Cancer, Spine Cancer, Liver Cancer, Brain Cancer, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa) – Industry Trends and Forecast to 2025
Request For Sample Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-radiotherapy-market
Some of the prominent participants operating in this market are globally
- Varian Medical Systems, Inc.,
- Elekta AB,
- Accuray, Inc.,
- CIVCO Medical Solutions,
- Brainlab AG,
- R. Bard, Inc.,
- IsoRay Medical, Inc.,
- Nordion, Inc.,
- RaySearch Laboratories AB,
- PRECISIS AG,
- Mevion Medical Systems, Inc.,
- Technicas Radiofiscas S.L.,
- Hitachi, Ltd.,
- Sumitomo Heavy Industries, Ltd.,
- Mitsubishi Electric Corporation,
- ProNova Solutions, LLC,
- ProTom International,
- Among others
Radiation therapy sole purpose is to treat tumors by targeting high beam of radiation on the affected region with minimal exposure to surrounding tissues. Modern radiotherapy uses high technology to try to achieve optimal local tumor control whilst minimizing treatment side effects to an acceptably low level. Aspects of the technology used for this goal include: computer systems for three-dimensional treatment planning and simulation, with accurate radiation dose deposition models and facilities for optimization of external radiation beam or brachytherapy source distribution; computer-controlled linear accelerators with dynamic beam collimation systems for external beam treatment or systems such as remote after loading for brachytherapy; and the use of radiation response models to characterize the treatment outcome and to enable the prediction of treatment outcomes for future patients’ treatments.
Global Radiotherapy Market is expected to reach at a CAGR of 7.7% in the forecast period of 2018 to 2025.
Opportunities in the Global Radiotherapy Market
- To strategically profile key players and comprehensively analyze their market position in terms of ranking and core competencies, and detail the competitive landscape for market leaders
- To describe and forecast the market, in terms of value, for various segments, by region Europe, North America, Asia-Pacific, South America, Middle East & Africa
- Comprehensive quantitative analysis of the industry is provided for the period of 2018-2025 to assist stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the key segments of the industry helps in understanding the trends in types of Radiotherapy Market across Global.
- To get a comprehensive overview of the Global Radiotherapy Market.
Want Full Report? Enquire Here @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-radiotherapy-market
Segmentation: Global Radiotherapy Market
Global radiotherapy market is segmented into three notable segments which are therapy type, product type and application.
On the basis of therapy type,
- Beam Radiotherapy
- Systemic Radiotherapy
On August 2016, Accuray announced the CE approval of Radixact Treatment Delivery System, Accuray Precision Treatment Planning System and iDMS Data Management System in Europe.
On the basis of product type,
- External Beam Radiotherapy
- Internal Radiotherapy Products
- Radiotherapy Softwares
- Systemic Radiotherapy
On June 2016, Elekta announces that Elekta’s Leksell Gamma Knife Icon has been cleared for clinical use by both the Japanese Ministry of Health, Labour and Welfare and the Nuclear Regulatory Commission in the United States. Icon is the world’s most precise and sophisticated system for radiosurgery treatment of certain brain tumors, vascular malformations and functional disorders.
On the basis of application,
- Prostate Cancer
- Breast Cancer
- Lung Cancer
- Spine Cancer
- Liver Cancer
- Brain Cancer
On Sptember 2016, Varian Medical Systems announced the launch of first of its kind 360 Oncology care management platform, the first software system designed to integrate and coordinate key elements of cancer care so patients and their cancer teams can collaborate on achieving the best outcomes.
Download Detailed TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-radiotherapy-market
Table of Contents:
- MARKET SEGMENTATION
- MARKET OVERVIEW
- EXECUTIVE SUMMARY
- PREMIUM INSIGHTS
- GLOBAL RADIOTHERAPY MARKET, BY THERAPY TYPE
- GLOBAL RADIOTHERAPY MARKET, BY PRODUCT TYPE
- GLOBAL RADIOTHERAPY MARKET, BY INDICATION
- GLOBAL RADIOTHERAPY MARKET, BY GEOGRAPHY
- GLOBAL RADIOTHERAPY MARKET, COMPANY SHARE
- COMPANY PROFILES
11.1. VARIAN MEDICAL SYSTEMS, INC.
11.1.1. COMPANY OVERVIEW
11.1.2. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)
11.1.3. DRIVERS EXPLAINED
188.8.131.52. DIVERSE PRODUCT PORTFOLIO:
184.108.40.206. STRONG RESEARCH AND DEVELOPMENT CAPABILITIES:
11.1.4. WEAKNESSES EXPLAINED
220.127.116.11. DEPENDENCE ON LIMITED NUMBER OF SUPPLIERS:
11.1.5. OPPURTUNITIES EXPLAINED
18.104.22.168. VARIAN COULD EXPAND ITS POSITION WITH IMAGING COMPONENTS BUSINESS’ SPIN-OFF:
22.214.171.124. ACQUISITIONS LIKELY TO ENHANCE VARIAN’S ONCOLOGY AND IMAGING BUSINESSES:
126.96.36.199. EXPANSION IN OPERATIONS IN THE U.S.:
188.8.131.52. INCREASING INCIDENCE OF CANCER TO DRIVE GLOBAL RADIATION THERAPY EQUIPMENT MARKET:
11.1.6. THREATS EXPLAINED
184.108.40.206. INTENSE COMPETITION COULD AFFECT VARIAN’S MARKET SHARE AND RESULTS OF OPERATION:
220.127.116.11. INCREASING MEDICAL COSTS IN CANCER TREATMENT AND CARE: 259
11.1.7. REVENUE ANALYSIS
11.1.8. PRODUCT PORTFOLIO
11.1.9. RECENT DEVELOPMENTS
11.1.10. DATA BRIDGE ANALYSIS
11.2. ELEKTA AB
11.2.1. COMPANY OVERVIEW
11.2.2. REVENUE ANALYSIS
11.2.3. PRODUCT PORTFOLIO
11.2.4. RECENT DEVELOPMENTS
11.2.5. DATA BRIDGE ANALYSIS
11.3.1. COMPANY OVERVIEW
11.3.2. REVENUE ANALYSIS
11.3.3. PRODUCT PORTFOLIO
11.3.4. RECENT DEVELOPMENTS
11.3.5. DATA BRIDGE ANALYSIS
11.4. ACCURAY, INC.
11.4.1. COMPANY OVERVIEW
11.4.2. REVENUE ANALYSIS
11.4.3. PRODUCT PORTFOLIO
11.4.4. RECENT DEVELOPMENTS
11.5. BRAINLAB AG
11.6. ION BEAM APPLICATIONS SA
11.7. MEVION MEDICAL SYSTEMS, INC.
11.8. ISORAY MEDICAL, INC.
11.9. NORDION (CANADA) INC.
11.10. RAYSEARCH LABORATORIES AB
11.11. PRECISIS AG
- RELATED REPORTS